Fig. 2
From: JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
JAKi inhibit the IL-1β synthesis from GM-CSF-stimulated THP-1 cells. THP-1 cells were stimulated with GM-CSF (20 ng/ml) for 24 h in the presence or absence of the pretreatment JAKi (tofacitinib, baricitinib, upadacitinib for 1 h) and supernatants were analyzed for IL-1β production by ELISA. Values represent the mean ± SD of three independent experiments. * p < 0.01 baricitinib-pretreated neutrophils versus those with tofacitinib or upadacitinib